AMP is the leading organization in the field of molecular diagnostics, and our meeting is “the premiere gathering” of molecular professionals. As technologies change and new challenges arise, members and non-members alike rely on our meeting to obtain the critical information needed to ensure that their patients receive the best care and best results.
Innovative Solutions for Automated Imaging
Since 1986, MetaSystems has been developing and manufacturing systems for automated microscope based imaging. Our close communication and relationships with our customers have been an essential part of the MetaSystems philosophy; the last 30 years have proven that this is a successful strategy. From humble beginnings, MetaSystems has grown into a leading solutions provider while still being connected to our roots as an independent, employee-owned, innovation-driven company.
MetaSystems’ latest innovation, Neon, is a dynamic, modern imaging platform which reliably manages cases, images, and results from single workstation environments to large multi-user, multi-site installations. The Neon imaging platform ensures that all relevant information is accessible whenever needed.
To learn more about our innovative laboratory solutions, we recommend beginning on the application pages. If you are already familiar with our product portfolio, you may proceed directly to the pages covering your product of interest. If you are unable to find what you are looking for, please do not hesitate to contact the MetaSystems partner in your region for assistance.
Are You Looking for Probes?
MetaSystems Probes now has its own website. If you are looking for MetaSystems XCyting DNA Probes, please visit the MetaSystems Probes website.
Her2 Amplification Analysis
"Fluorescence in situ hybridization (FISH) is a widely used technique for the determination of HER2 status in breast cancer. [...] MetaSystems has developed a new classifier which is able to recognize nuclei within tissue sections in order to determine the HER2 amplification status on nuclei basis. [...] Our results showed an excellent concordance between manual scoring, our reference method, and nuclei-sampling analysis [...]. We conclude that the new image analysis software Metafer 4 classifier is a reliable tool to evaluate the unequivocal status of HER2 in breast cancer specimens and it is ready to be implemented in clinics."
Seal of Approval 2018: "Commitment to Sustainability"
MetaSystems is proud to be committed to sustainable business and to the safeguarding of social and ecological standards. As a result of this philosophy, MetaSystems recently was awarded again the seal of approval 2018 "Commitment to Sustainability" by the certification body of the German institute for Sustainability and Economy in accordance with di-no. - Procedural Regulation D-17/400780, and documented in Analysis Report No. 4017 3201 and relevant Audit Report No. 4017 3201. MetaSystems will take this award as inducement to continue with our sustainable business practices and socially responsible activities.
Radiation Biodosimetry Workshop at KIRAMS, Seoul, Korea
Biological dosimetry (biodosimetry) is an imminent part of the countermeasures in the aftermath of radiation accidents. Based on the quantification of markers in the blood of affected victims (e.g., dicentric chromosomes, micronuclei, or translocations), the method allows for a precise and retrospective estimation of the dose the persons have received. The National Radiation Emergency Medical Center (NREMC) in the Korea Institute of Radiological & Medical Sciences (KIRAMS) recently hosted a MetaSystems workshop on the implementation of Metafer for biodosimetry imaging automation. The workshop has been supported by our Korean partner Mirax Corporation.